These data support our hypothesis that lung cancer cells exposed to cisplatin enrich for a subpopulation of ALDH1+ve cells with stem-like characteristics which may, at least in part, account for the resistance phenotype exhibited by these cells. The gene discussed is ALDH1A1; the disease is lung cancer.